+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ambrx Inc - logo

Ambrx is a biopharmaceutical company that produces protein therapeutics which reduce frequency of dosing, and optimizes efficiency and safety. Ambrx, Inc. was founded in 2003 and is based in La Jolla, California. The company collaborates with Mabspace Biosciences for oncology purposes in China and internationally. They develop a range of products such as ADC, long-acting protein product candidates, collaboration product and product candidates, and other early-stage programs.

Colon Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1184 Pages
  • Global
From
Synthetic Biology: Global Markets - Product Thumbnail Image

Synthetic Biology: Global Markets

  • Report
  • February 2022
  • 344 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2020 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2766 Pages
  • Global
From
Prostate Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3323 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2289 Pages
  • Global
From
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019 - Product Thumbnail Image

C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 136 Pages
  • Global
From
Loading Indicator